Athan Kang (10) | STAFF REPORTER
Tirzepatide, or commonly known as Mounjaro, is an injectable medication that is used to treat patients with type 2 diabetes. However, more people are using this drug to lose weight instead of treating diabetes. The demand for this medication continues to increase as this weight loss trend continues, leading to several in-need, diabetic individuals struggling to access Mounjaro.
A major study comparing Tirzapatide to other diabetes medications such as Ozempic showed that the ingredients in Mounjaro are more effective at reducing blood sugar levels and weight loss. Other researchers suggest that Tirzepatide is likely stronger than other diabetes drugs on the market.
As of now, the Food and Drug Administration only approves of Mounjaro for type 2 diabetes treatment, as they stated that it is not a weight loss medication. Nonetheless, people continue to abuse it as a substitute for Wegovy, a similar drug approved for weight loss purposes.
The main issue behind this viral treatment are its lingering side effects. Along with significant weight loss, Tirzapatide causes more severe effects than Ozempic and Wegovy like nausea, vomiting, diarrhea, and stomach pain. It is also said that in rare cases, a person may experience more adverse health consequences such as renal failure, pancreatitis, and gastrointestinal bleeding.
Doctors recommend that those taking Mounjaro must be under medical supervision due to the risks that this drug carries. Tirzepatide is a medication designed for individuals with type 2 diabetes and should be taken with diet and exercise, not as a weight loss remedy.
In the end, Mounjaro has taken the weight loss and diabetes market by storm. Medications for diabetic purposes continue to strike popularity throughout the market for their weight-reducing miracles, leaving actual diabetic patients in a panic trying to find the proper treatment for their condition.
